Contact: Chorom Pak, 213-422-1352, cpak@lynxbiosciences.com
UW-Madison cancer treatment spinoff takes top honor in life science at Governor’s Business Plan Contest
MADISON – Lynx Biosciences, a business aiming to refine treatment decisions for multiple myeloma, took the life science prize at the Governor’s Business Plan Contest during the 14th annual Wisconsin Entrepreneurs’ Conference in Madison.
Lynx is developing technology to choose the chemotherapy drug most likely to benefit a blood cancer patient by analyzing how the tumor cells respond to drugs. Founder Chorom Pak says the company measures tumor cell survival, not biological markers, and therefore could be suitable to evaluate any drug.
“There were some strong competitors, so we were happy to be among the finalists,” says Pak, who earned a doctorate in molecular and cellular pharmacology from UW-Madison. “It was tough to whittle down all our information into a seven-minute presentation. We made the top 25 last year, and this year, we had to refine our plan and to think about more business aspects.”
During the competition, 206 business plans from around the state were winnowed to 13 finalists.
Five plans from UW-Madison, in advanced manufacturing, information technology and life science, made the final round. Contestants that emerged from UW-Madison won the grand prize in 2014 (Elucent Medical) and 2015 (BluDiagnostics).
The contest was organized by the Wisconsin Technology Council.
